Pembrolizumab 100mg/4ml Solution from Canada
Pembrolizumab injection is an anti-PD-1 antineoplastic monoclonal antibody for various cancers, in 100mg/4ml vials for IV infusion. HTS 3004.90.92.16 applies to these dosed immunosuppressive therapies.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Adventitious agent removal validation required for monoclonal imports
• Concentration verification prevents dilution disputes at entry